prof. dr. I.P. (Ido) Kema

prof. dr. I.P. (Ido) Kema


  1. Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism

    Heida, J. E., Minović, I., van Faassen, M., Kema, I. P., Boertien, W. E., Bakker, S. J. L., van Beek, A. P. & Gansevoort, R. T., 4-Nov-2020, In : American Journal of Nephrology. p. 1-10 10 p., 000511000.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Potential of metformin to modify the gut microbiota and prevent inflammation in nondiabetic people with HIV.

    Isnard, S., Lin, J., Frombuena, B., Varin, T. V., Marette, A., Planas, D., Messaoudene, M., Routy, B., Van der Ley, C., Kema, I., Ancuta, P., Angel, J. & Routy, J-P., Apr-2020, In : Cancer Research. 80, 8, p. 26-27 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. An epigenome-wide association study identifies multiple DNA methylation markers of exposure to endocrine disruptors

    BIOS Consortium, Lu, X., Fraszczyk, E., van der Meer, T. P., van Faassen, M., Bloks, V. W., Kema, I. P., van Beek, A. P., Li, S., Franke, L., Westra, H-J., Xu, X., Huo, X., Snieder, H., Wolffenbuttel, B. H. R. & van Vliet-Ostaptchouk, J. V., 8-Sep-2020, In : Environment international. 144, 8 p., 106016.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (311) »

  1. Guided Treatment in Optimal Selected Cancer Patients (GUTS) (Organisational unit)

    Ido Kema (Member)


    Activity: MembershipMembership of networkAcademic

View all (1) »

ID: 207810